Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review
Justin P. Reinert, Kayla N. Colunga, Alexandria Etuk, Victoria Richardson, Rebecca L. Dunn
Expert Review of Clinical Pharmacology July 10, 2020 DOI: 10.1080/17512433.2020.1794811 via OpenAlex
Summary
AI-generated from the abstractUse of salvia, kratom, and psilocybin mushrooms is rising globally, and healthcare practitioners should consider these substances when triaging overdose cases. Although overdoses from these agents are not typically fatal, clinicians need to be prepared to identify them as a possible cause and provide appropriate supportive care.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Health care Cinahl Traditional medicine Psychiatry |
| Citations | 11 |
| Key finding | Clinicians should consider salvia, kratom, and psilocybin mushrooms as potential etiologies in overdose scenarios due to increased global use, though such overdoses are not typically fatal. |
Abstract
Salvia, kratom, and psilocybin mushrooms may not be an initial consideration when healthcare practitioners are triaging an overdose scenario; however, data from around the world demonstrate an increased use of these agents. While not typically fatal, clinicians must be prepared to assess these as a potential etiology of overdoses and provide appropriate supportive care.